Report
EUR 500.00 For Business Accounts Only

Proxy Report - 28/05/2018

Cette année la Société change son mode de gouvernance et passe d’un Conseil de Surveillance à un Conseil d’Administration. Selon Proxinvest, il eut été préférable pour la société de saisir l'opportunité de ce changement de mode de gouvernance et de proposer des membres libres de tout conflit d'intérêt au sein du Conseil d'administration (résolutions 18 à 23). Par ailleurs, nous émettons des réserves sur les motivations de la Société à changer ce mode de gouvernance, et sur la possibilité d'une réunion des fonctions de Président et Directeur Général.

Nous nous opposerons au vote sur la rémunération de Michèle Lesieur, Présidente du Conseil, considérant que la Société manque de transparence : aucune pondération, aucune cible ni aucun taux de réalisation n'est communiqué. Par ailleurs, quelques 412 000 €, correspondant à l’attribution de 300 000 actions de performance, ne sont pas pris en compte dans le calcul de la rémunération totale (résolution 10).

Proxinvest s’opposera aux résolutions relatives aux augmentations de capital (résolutions 24 à 26, 30 à 33 et 38) dans la mesure où celles-ci appliquent des plafonds excessifs, et dont l’autorisation est parfois maintenue en période d’offre publique.

Underlying
Supersonic Imagine SA

Supersonic Imagine Sa. SuperSonic Imagine SA is a French company engaged in the ultrasound medical imaging field. The Company has developed the Aixplorer system, which uses the MultiWave technology, enabling the user to detect, characterize and, in the future, treat palpable and non-palpable masses. The MultiWave technology is based on combining two types of waves: an ultrasound wave that provides imaging in B-mode, and a shear wave, which measures and displays the stiffness of tissue in kilopascals. Aixplorer has several clinical applications: breast (and 3D breast), thyroid, abdomen, liver, musculo-skeletal, prostate, and gynaecological (excluding obstetrics). SuperSonic Imagine has both a direct sales and distribution network in more than 50 countries, including Hologic Inc for the breast care market in the United States, and Canon Marketing in Japan.

Provider
Proxinvest
Proxinvest

Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.

Proxinvest main services are :

  • ​Proxy reports
  • Definition and monitoring of client customized voting guidelines
  • Corporate Governance Data and Rating
  • Thematic research
  • Engagement support

Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.

Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.

As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide. 

Other Reports on these Companies
Other Reports from Proxinvest

ResearchPool Subscriptions

Get the most out of your insights

Get in touch